<description>&lt;p&gt;Trials of a cancer 'vaccine' have begun and presenter James meets Steve, one of the first patients to trial the new treatment, Steve remembers his shock at being diagnosed with colorectal cancer in his 40s and tells the story of how he became involved in this pioneering research into tackling cancer.&lt;/p&gt;&lt;p&gt;The vaccine is based on the same mRNA technology as the Pfizer-BioNTech COVID-19 vaccine and James heads to the University of Cambridge to find out how the early work into cancer vaccines became the foundation for the rapid rollout of the covid vaccine. &lt;/p&gt;&lt;p&gt;In the lab, molecular biologist Dr Anne Willis and immunologist Dr James Thaventhiran explain how the vaccine is personalised to target the unique make-up of an individual patients' cancer cells, and how if the trials are successful they could open the door to mRNA treatments being used to treat a wide range of diseases.&lt;/p&gt;&lt;p&gt;Also, Imperial College London cyber security researcher Dr Saira Ghafur joins James in the studio to explain why healthcare is a growing target for cyber attackers and how we can prepare for the next one because, as Saira says, it really is a case of "when" not "if".&lt;/p&gt;&lt;p&gt;Presented by James Gallagher
Produced by Tom Bonnett with Hannah Robins
Assistant Producer: Katie Tomsett
Editor: Holly Squire&lt;/p&gt;</description>

We meet a patient on a revolutionary cancer vaccine trial, plus planning for cyber attacks

Trials of a cancer 'vaccine' have begun and presenter James meets Steve, one of the first patients to trial the new treatment, Steve remembers his shock at being diagnosed with colorectal cancer in his 40s and tells the story of how he became involved in this pioneering research into tackling cancer.The vaccine is based on the same mRNA technology as the Pfizer-BioNTech COVID-19 vaccine and James heads to the University of Cambridge to find out how the early work into cancer vaccines became the foundation for the rapid rollout of the covid vaccine. In the lab, molecular biologist Dr Anne Willis and immunologist Dr James Thaventhiran explain how the vaccine is personalised to target the unique make-up of an individual patients' cancer cells, and how if the trials are successful they could open the door to mRNA treatments being used to treat a wide range of diseases.Also, Imperial College London cyber security researcher Dr Saira Ghafur joins James in the studio to explain why healthcare is a growing target for cyber attackers and how we can prepare for the next one because, as Saira says, it really is a case of "when" not "if".Presented by James Gallagher
Produced by Tom Bonnett with Hannah Robins
Assistant Producer: Katie Tomsett
Editor: Holly Squire

Cancer vaccine trials and planning for cyber attacks

<description>&lt;p&gt;Mpox is spreading and it’s been classified a public health emergency by the World Health Organization. Presenter James Gallagher meets Professor Trudie Lang from the University of Oxford who has been working in the areas affected to discuss what it means for people in the countries it’s already reached and whether its spread can be stopped.&lt;/p&gt;&lt;p&gt;James also puts your questions on statins to Professor Naveed Sattar, and we hear the story of Simon who works in the outdoors as a landscape manager. He was having bouts of severe illness and was struggling to understand what was behind it. The answer? He’d had successive bites from ticks and was having symptoms of an allergic reaction when he was eating meat. He had alpha gal syndrome, commonly known as a meat allergy. We hear how it’s caused debilitating changes to his life.&lt;/p&gt;&lt;p&gt;We also hear from Consultant Immunologist Dr Rachael O’Brian who has been documenting the first case of alpha gal syndrome her team have been diagnosing at Frimley Park Hospital in Surrey.&lt;/p&gt;&lt;p&gt;Presenter: James Gallagher
Producer: Tom Bonnett
Assistant Producer: Katie Tomsett
Editor: Holly Squire&lt;/p&gt;</description>

Mpox is classed a public health emergency, statins questions and tick-borne meat allergies

Mpox is spreading and it’s been classified a public health emergency by the World Health Organization. Presenter James Gallagher meets Professor Trudie Lang from the University of Oxford who has been working in the areas affected to discuss what it means for people in the countries it’s already reached and whether its spread can be stopped.James also puts your questions on statins to Professor Naveed Sattar, and we hear the story of Simon who works in the outdoors as a landscape manager. He was having bouts of severe illness and was struggling to understand what was behind it. The answer? He’d had successive bites from ticks and was having symptoms of an allergic reaction when he was eating meat. He had alpha gal syndrome, commonly known as a meat allergy. We hear how it’s caused debilitating changes to his life.We also hear from Consultant Immunologist Dr Rachael O’Brian who has been documenting the first case of alpha gal syndrome her team have been diagnosing at Frimley Park Hospital in Surrey.Presenter: James Gallagher
Producer: Tom Bonnett
Assistant Producer: Katie Tomsett
Editor: Holly Squire

Mpox, your statins questions and tick-borne meat allergies

<description>&lt;p&gt;Richard was 10 when he started smoking, and by the age of 35, he had given up on giving up smoking. But thanks to vaping he quit, almost by accident, in just a few months. &lt;/p&gt;&lt;p&gt;However, vaping has been in the spotlight recently, with the rise of disposable vapes and awareness of more young people starting to vape. &lt;/p&gt;&lt;p&gt;So, is vaping a useful tool to help people get off of cigarettes, or is it a gateway for young people into smoking? We hear from young people about their experiences and thoughts on vaping. &lt;/p&gt;&lt;p&gt;In the studio, Dr Sarah Jackson, Principal Research Fellow at UCL Alcohol and Tobacco Research Group, and Hazel Cheeseman, Deputy Chief Executive of ‘Action on Smoking and Health’, are with James to discuss. &lt;/p&gt;&lt;p&gt;Plus, podiatrist Dr Ivan Bristow is on hand to advise why James and listener Linda have had a hard time getting rid of their verrucas for years. We find out exactly what the warts are and what options are available to help our body tackle them. &lt;/p&gt;&lt;p&gt;Presenter: James Gallagher 
Producer: Hannah Fisher 
Assistant producer: Katie Tomsett
Editor: Holly Squire&lt;/p&gt;</description>

Is vaping a tool to quit smoking or a gateway to starting? And why verrucas won't budge.

Richard was 10 when he started smoking, and by the age of 35, he had given up on giving up smoking. But thanks to vaping he quit, almost by accident, in just a few months. However, vaping has been in the spotlight recently, with the rise of disposable vapes and awareness of more young people starting to vape. So, is vaping a useful tool to help people get off of cigarettes, or is it a gateway for young people into smoking? We hear from young people about their experiences and thoughts on vaping. In the studio, Dr Sarah Jackson, Principal Research Fellow at UCL Alcohol and Tobacco Research Group, and Hazel Cheeseman, Deputy Chief Executive of ‘Action on Smoking and Health’, are with James to discuss. Plus, podiatrist Dr Ivan Bristow is on hand to advise why James and listener Linda have had a hard time getting rid of their verrucas for years. We find out exactly what the warts are and what options are available to help our body tackle them. Presenter: James Gallagher 
Producer: Hannah Fisher 
Assistant producer: Katie Tomsett
Editor: Holly Squire

What should we do about vaping?

<description>&lt;p&gt;The inventor of statins, Akira Endo, died this summer. When he was prescribed statins in older age for high cholesterol he refused, preferring to improve his diet and lifestyle instead. But how far can changes like these really go to reduce our bad cholesterol and our overall risk of cardiovascular disease? Our resident GP Margaret McCartney and Professor of Cardiometabolic Medicine Naveed Sattar discuss. &lt;/p&gt;&lt;p&gt;Dermatologist Dr Alexandra Banner gives us the lowdown on how to treat sunburn, including reviewing some of your surprising home remedies. &lt;/p&gt;&lt;p&gt;And what is snus and does it enhance sporting performance? Professor Toby Mundel explains. &lt;/p&gt;&lt;p&gt;Presenter: James Gallagher 
Producers: Hannah Robins and Tom Bonnett 
Assistant producer: Katie Tomsett 
Editor: Holly Squire&lt;/p&gt;</description>

Plus, sunburn remedies and how snus might enhance sporting performance

The inventor of statins, Akira Endo, died this summer. When he was prescribed statins in older age for high cholesterol he refused, preferring to improve his diet and lifestyle instead. But how far can changes like these really go to reduce our bad cholesterol and our overall risk of cardiovascular disease? Our resident GP Margaret McCartney and Professor of Cardiometabolic Medicine Naveed Sattar discuss. Dermatologist Dr Alexandra Banner gives us the lowdown on how to treat sunburn, including reviewing some of your surprising home remedies. And what is snus and does it enhance sporting performance? Professor Toby Mundel explains. Presenter: James Gallagher 
Producers: Hannah Robins and Tom Bonnett 
Assistant producer: Katie Tomsett 
Editor: Holly Squire

Can diet and exercise ever replace statins?

<description>&lt;p&gt;From the Hay Festival, James and a panel of experts explain what we can all do to help ourselves age well. &lt;/p&gt;&lt;p&gt;We discover what’s going on in our bodies when we age, the difference between biological and chronological age, as well as getting the audience moving for a physical test. &lt;/p&gt;&lt;p&gt;James is joined by gerontologist Sarah Harper from the University of Oxford, biomedical scientist Georgina Ellison-Hughes from King’s College London, and doctor Norman Lazarus to understand how exercise, diet, and mental health all have a part to play in how we age. &lt;/p&gt;&lt;p&gt;Presenter: James Gallagher  
Producer: Gerry Holt 
Editor: Holly Squire&lt;/p&gt;</description>

James and the Hay Festival audience try to conquer ageing, guided by a panel of experts.

From the Hay Festival, James and a panel of experts explain what we can all do to help ourselves age well. We discover what’s going on in our bodies when we age, the difference between biological and chronological age, as well as getting the audience moving for a physical test. James is joined by gerontologist Sarah Harper from the University of Oxford, biomedical scientist Georgina Ellison-Hughes from King’s College London, and doctor Norman Lazarus to understand how exercise, diet, and mental health all have a part to play in how we age. Presenter: James Gallagher  
Producer: Gerry Holt 
Editor: Holly Squire

How can we age well?

Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.

Inside Health

Details

Recent Episodes